SO-27 Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

Subjects

Subjects :

Oncology
medicine.medical_specialty
Colorectal cancer
business.industry
Low dose
Checkmate
Microsatellite instability
Ipilimumab
Hematology
medicine.disease
Internal medicine
medicine
DNA mismatch repair
Nivolumab
Previously treated
business
medicine.drug

Details

ISSN :

09237534

Volume :

32

Database :

OpenAIRE

Journal :

Annals of Oncology

Accession number :

edsair.doi...........51ce2ddc66bf9f12eb21b73b6424a933

Full Text :

https://doi.org/10.1016/j.annonc.2021.05.051